{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:59:43Z","timestamp":1740149983144,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.1007\/s12029-017-9995-9","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T22:03:01Z","timestamp":1502143381000},"page":"147-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gallbladder Adenocarcinoma as the First Manifestation of Germline BRCA1 Mutation"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2930-533X","authenticated-orcid":false,"given":"Ahmad","family":"Al-Taee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammara","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel","family":"Jallad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"issue":"9","key":"9995_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1429","volume":"4","author":"II Wistuba","year":"2004","unstructured":"Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4(9):695\u2013706.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"9995_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591\u2013602.","journal-title":"Int J Cancer"},{"issue":"6","key":"9995_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349\u201364.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"9995_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15(2):168\u201381.","journal-title":"Oncologist"},{"issue":"18","key":"9995_CR5","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst. 2002;94(18):1365\u201372.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"9995_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S0959-8049(99)00135-5","volume":"35","author":"O Johannsson","year":"1999","unstructured":"Johannsson O, Loman N, Moller T, Kristoffersson U, Borg A, Olsson H. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer. 1999;35(8):1248\u201357.","journal-title":"Eur J Cancer"},{"issue":"24","key":"9995_CR7","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1002\/cncr.29664","volume":"121","author":"EE Salo-Mullen","year":"2015","unstructured":"Salo-Mullen EE, et al. Identification of germline genetic mutations in patients with pancreatic cancer. Cancer. 2015;121(24):4382\u20138.","journal-title":"Cancer"},{"issue":"12","key":"9995_CR8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/bjc.2012.483","volume":"107","author":"J Iqbal","year":"2012","unstructured":"Iqbal J, et al. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2012;107(12):2005\u20139.","journal-title":"Br J Cancer"},{"issue":"23","key":"9995_CR9","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98(23):1694\u2013706.","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"9995_CR10","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"C. Breast Cancer Linkage","year":"1999","unstructured":"C. Breast Cancer Linkage. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91(15):1310\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"9995_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4161\/cbt.12.3.16292","volume":"12","author":"A Sonnenblick","year":"2011","unstructured":"Sonnenblick A, et al. Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy. Cancer Biol Ther. 2011;12(3):165\u20138.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"9995_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/bjc.2015.220","volume":"113","author":"I Lohse","year":"2015","unstructured":"Lohse I, et al. BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts. Br J Cancer. 2015;113(3):425\u201332.","journal-title":"Br J Cancer"},{"issue":"7","key":"9995_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/bjc.2016.67","volume":"114","author":"JS Brown","year":"2016","unstructured":"Brown JS, Kaye SB, Yap TA. PARP inhibitors: the race is on. Br J Cancer. 2016;114(7):713\u20135.","journal-title":"Br J Cancer"},{"issue":"46","key":"9995_CR14","doi-asserted-by":"publisher","first-page":"10254","DOI":"10.3748\/wjg.v22.i46.10254","volume":"22","author":"Y Xie","year":"2016","unstructured":"Xie Y, et al. Response of BRCA1-mutated gallbladder cancer to olaparib: a case report. World J Gastroenterol. 2016;22(46):10254\u20139.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"9995_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/gim.2015.58","volume":"17","author":"T May","year":"2015","unstructured":"May T, Strong KA, Khoury MJ, Evans JP. Can targeted genetic testing offer useful health information to adoptees? Genet Med. 2015;17(7):533\u20135.","journal-title":"Genet Med"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-017-9995-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-017-9995-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-017-9995-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:53:44Z","timestamp":1628600024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-017-9995-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3,15]]}},"alternative-id":["9995"],"URL":"https:\/\/doi.org\/10.1007\/s12029-017-9995-9","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"type":"print","value":"1941-6628"},{"type":"electronic","value":"1941-6636"}],"subject":[],"published":{"date-parts":[[2017,8,8]]},"assertion":[{"value":"8 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}}]}}